Citadel Advisors’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-332
| Closed | -$15.3K | – | 6900 |
|
|
2024
Q2 | $15.3K | Buy |
332
+230
| +225% | +$10.6K | ﹤0.01% | 5462 |
|
|
2024
Q1 | $2.18K | Sell |
102
-425
| -81% | -$9.08K | ﹤0.01% | 5860 |
|
|
2023
Q4 | $10.7K | Buy |
+527
| New | +$10.7K | ﹤0.01% | 5523 |
|
|
2023
Q3 | – | Sell |
-128
| Closed | -$3.13K | – | 6637 |
|
|
2023
Q2 | $3.13K | Sell |
128
-1,973
| -94% | -$48.2K | ﹤0.01% | 5509 |
|
|
2023
Q1 | $50.2K | Buy |
2,101
+1,644
| +360% | +$39.3K | ﹤0.01% | 5156 |
|
|
2022
Q4 | $12.9K | Sell |
457
-2,036
| -82% | -$57.6K | ﹤0.01% | 5642 |
|
|
2022
Q3 | $62K | Sell |
2,493
-1,176
| -32% | -$29.2K | ﹤0.01% | 5251 |
|
|
2022
Q2 | $110K | Sell |
3,669
-809
| -18% | -$24.3K | ﹤0.01% | 5253 |
|
|
2022
Q1 | $124K | Buy |
4,478
+1,147
| +34% | +$31.8K | ﹤0.01% | 5538 |
|
|
2021
Q4 | $86K | Buy |
3,331
+914
| +38% | +$23.6K | ﹤0.01% | 5977 |
|
|
2021
Q3 | $86K | Sell |
2,417
-1,932
| -44% | -$68.7K | ﹤0.01% | 5940 |
|
|
2021
Q2 | $183K | Buy |
4,349
+2,749
| +172% | +$116K | ﹤0.01% | 5630 |
|
|
2021
Q1 | $70K | Buy |
+1,600
| New | +$70K | ﹤0.01% | 6004 |
|
|
2020
Q4 | – | Sell |
-848
| Closed | -$45K | – | 5690 |
|
|
2020
Q3 | $45K | Buy |
+848
| New | +$45K | ﹤0.01% | 4414 |
|
|
2019
Q2 | – | Sell |
-379
| Closed | -$31K | – | 5184 |
|
|
2019
Q1 | $31K | Buy |
+379
| New | +$31K | ﹤0.01% | 4348 |
|
|
2016
Q1 | – | Sell |
-82
| Closed | -$83K | – | 4055 |
|
|
2015
Q4 | $83K | Buy |
+82
| New | +$83K | ﹤0.01% | 3302 |
|
|
2015
Q3 | – | Sell |
-12
| Closed | -$22K | – | 4341 |
|
|
2015
Q2 | $22K | Sell |
12
-9
| -43% | -$16.5K | ﹤0.01% | 3569 |
|
|
2015
Q1 | $25K | Hold |
21
| – | – | ﹤0.01% | 3495 |
|
|
2014
Q4 | $31K | Buy |
21
+10
| +91% | +$14.8K | ﹤0.01% | 3511 |
|
|
2014
Q3 | $20K | Sell |
11
-1
| -8% | -$1.82K | ﹤0.01% | 3304 |
|
|
2014
Q2 | $27K | Buy |
+12
| New | +$27K | ﹤0.01% | 3222 |
|